BSECompany Update6d ago · 14 Aug 2026, 05:32 pm
Unaudited financial results for the quarter ended June 30, 2026, were published in the English and Tamil newspapers and are attached herewith for your reference.
Binny Ltd · 514215
✦ AI SummaryResults
Binny Ltd published unaudited financial results for the quarter ended June 30, 2026, which are available on the company's website and stock exchanges' websites.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Binny Ltd - 514215 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
a4d78c66-5bd3-4925-a79d-ac9a3f931de0.pdf
View document text
Business Standard cuennai | FRIDAY1,4 AUGUST 2026
GSK SIL INVESTMENTS LIMITED BINNY LIMITED
GlaxoSmithKline Pharmaceuticals Limited
CIN : L17301RJ1934PLC002761 CIN : L17111TN1969PLC005736
Corporate Identity Number (CIN): L24239MH1924PLC001151 Regd. Office : Pachpahar Road, Bhawanimandi-326502 (Rajasthan) Tel. No.: 07433-222082; Regd. Office: No.1, Cooks Road, Perambur, Chennai 600 012
GSK House, Dr. Annie Besant Road, Worli, Mumbai 400030 Email: complianceofficer@silinvestments.in; Website : www.silinvestments.in Website : https://binnylimited.in/; email : binny@binnyltd.in; T : 044 - 2662 1053; F : 044 - 2662 1056
Telephone: 022-24959595 + Email: in.investorquery@gsk.com
Website: https://india-pharma.gsk.com STATEMENT OF UNAUDITED STANDALONE AND EXTRACT OF UNAUDITED FINANCIAL RESULTS
FOR THE QUARTER ENDED 30TH JUNE 2026
NOTICE CONSOLIDATED FINANCIAL RESULTS (Rs. in Lakhs)
CM oe mm pb ae nr is e sa re A cth ,e re 2b 0y 1 3i nf ro er am de d wit th ha t Cp ou mrs pu aa nn it e sto (se Mc at ni aon g e1 m1 e0 n to f at nh de FOR THE QUARTER ENDED 30" JUNE, 2026 Particulars Qu 3a 0r .t 0e 6r . e 20n 2d 6e d | Qu 3a 0r .t 0e 6r . e 20n 2d 5e d Y 3e 1a .r 0 3e .n 2d 0e 26d
Administration) Rules, 2014, the Company has completed the dispatch Unaudited Unaudited Audited
The Board of Directors of the Company, at their meeting held on 13" August, 2026
of the Postal Ballot Notice, to all the members whose name appears .| Total income from operations (net) 2,196.84 943.68 7,038.51
on the Register of Members / List of Beneficial Owners as on Friday, approved the unaudited standalone and consolidated financial results of the .| Net Profit/ (Loss) for the Period (before Tax,
7" August 2026 (cut-off date) through electronic mode only to those
Exceptional and / or Extraordinary items) 1,769.29 704.57 5,104.77
Members whose email address are registered with the Company / Company forthe quarter ended 30° June, 2026.
.| Net Profit/ (Loss) for the period before tax
Depository Participant, in compliance with the MCA Circular dated
April 8, 2020, April 13, 2020, and subsequent circulars issued by the The full financial results of the Company along with the Auditor's Limited Review (after Exceptional and / or Extraordinary items) 1,769.29 704.57 5,104.77
Ministry of Corporate Affairs (“MCA”) the latest being September 22, .| Net Profit/ (Loss) for the period after tax
Report, are available on the Stock Exchanges websites at www.b seindia.com and
2025 (hereinafter collectively referred to as “MCA Circulars”), for the (after Exceptional and / or Extraordinary items) 1,335.06 371,22 3,599.76
following resolutions: www.nseindia.com and are also posted on the Company's website at .| Total Comprehensive Income for the period
Item No Description of the Resolution {Comprising Profit / (loss) for the period (after tax)
https://www.silinvestments.in/pdfs/Unaudited/UnAud_June2026.pdf which and Other Comprehesive Income (after tax)} 1,329.85 370.00 3,624.44
1 Ordinary Resolution - Appointment of Ms. Karine J F
Natland (DIN: 11870917)) as a Non-Executive Director can be accessed by scanning the Quick Response (QR) code. .| Equity Share Capital 1,115.97 1,115.97 1,115.97
2 Ordinary Resolution - Re-appointment of Mr. Bhushan .| Reserves (excluding Revaluation Reserve) 49,733.68 44,033.43 48,403.83
Akshikar (DIN: 09112346) as Managing Director .| Earnings Per Share (of Rs. 5/- each)
In compliance of the Companies Act, SEBI (Listing Obligations and (for continuing and discontinued operations)
Disclosure Requirements) Regulations, 2015 and the MCA Circulars, (Not Annualised)
the communication of assent or dissent of the Members would only (a) Basic (in Rs.}
take place through the remote e-voting system. The Company has (b) Diluted (in Rs.)
engaged the services of KFin Technologies Limited (“Kfin”) for the
purpose of providing e-voting facility to all its members. Members are Notes :
requested to note that the voting, through e-voting mode commences 1. The above is an extract of the detailed format of Quarterly Financial Results filed with the Stock Exchange
on 9.00 a.m. (IST) Friday, 14 August 2026 and ends at 5.00 p.m. (IST) under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. |
on Sunday,13" September, 2026The KFin evoting platform would be The full format of the Quarterly Financial Results are available on the Company's Website
disabled thereafter. (www.binnylimited.in) and Stock Exchange's website (www.bseindia.com).
The Board of Directors has appointed Mr. P. N. Parikh, (Membership 2. The above extract has been prepared in accordance with the Companies (Indan Accounting standards)
No. FCS 327) and failing him Ms. Jigyasa Ved (Membership No. FCS Rules, 2015 (IND AS) prescribed under section 133 of the Companies Act, 2013 read with Companies
6488) of Parikh & Associates, Practicing Company Secretaries as the For SIL INVESTMENTS LIMITED (Indian Accounting Standards) Rules, 2015 (as amended).
Scrutinizer (‘Scrutinizer’) for conducting the postal ballot and e-voting For Binny Limited
process in a fair and transparent manner. Place : Kolkata (C. S. Nopany) Place: Chennai Sdi-
Members whose names appear on the Register of Members / List of Date : 13" August, 2026 Chairman Date : 12.08.2026 Sathya W hN oa lr ea y Ta in ma en D B ia rel ca tk or ri shnan
Beneficial Owners as on Friday, 7" August 2026 will be considered for
the purpose of voting. Note : The above intimation is in accordance with Regulation 33 read with Regulation 47(1) of
XTGLOBAL INFOTECH LIMITED
The results of the postal ballot shall be declared by the Chairperson or the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
any other person authorized by her, on or before 15" September 2026
CIN: L72200TG1986PLC006644
and communicated to the stock exchanges, depositories, registrar and
share transfer agents and shall also be displayed on the Company’s Plot No 31P and 32, ToweAr, Ramky Selenium, Financial District, Nanakramguda, Hyderabad, Telangana—500032
website https://india-pharma.gsk.com/en-in/investors/shareholder- E-mail- company.secretary@xtglobal.com, Tel: 040-66353456 Website: xtglobal.com
information/postal-ballot/ STATEMENT OF FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026
GANGES SECURITIES LIMITED
For any queries / grievances relating to e-voting by postal ballot, (Rs. In lakhs)
Members are requested to contact Mr. Anandan K, AVP at KFin Registered Office : P.O. Hargaon, District Sitapur, Uttar Pradesh - 261 121 STANDALONE CONSOLIDATED
Technologies Limited, Unit: GlaxoSmithKline Pharmaceuticals Limited, Phone (05862) 256220, Fax (05862) 256225, CIN :L74120UP2015PLC069869 PARTICULARS QUARTER ENDED YEAR ENDED} QUARTER ENDED YEAR ENDED}
Selenium Tower B, Plot No. 31 & 32, Gachibowli, Financial District, Web-site : www.birla-sugar.com, E-mail : gangessecurities@birlasugar.org 30.06.2026]31.03.2026]30.06.2025)31 03.2026 [30.06.2026 ]31.03.2026]30.06.2025]31.03.2026
Hyderabad-500032, e-mail: einward.ris@kfintech.com, Contact No.: Reviewed | Audited | Reviewed | (Audited) | Reviewed] Audited | Reviewed | (Audited)
040-67 162222 & Toll-free No. 1800 309 4001. EXTRAt F THE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026
Total Income 2,022.78 | 1,986.62 | 1,869.33 | 7,655.20 | 9,372.69 | 8,960.51 | 9,236.61 ]36,924.97
For GlaxoSmithKline Pharmaceuticals Limited (2 In lakhs)
Net Profit (Loss) from Ordinary 234.61] 238.53 133.11] 815.23] 524.02] 206.64) 411.68 | 1,717.30
Ajay Nadkarni Standalone Consolidated activities (before tax, Exceptional
Vice President - Administration, ir Particulars Quarter Year Quarter | Quarter Year Quarter 8/or extra-ordinary items
Place : Mumbai Real Estate & Company Secretary ended ended ended ended ended ended Net Profit {Loss} (before tax, After | 234.61] 238.53 133.11] 815.23] 524.02] 206.64) 411.68 | 1,717.30
Dated : 13 August 2026 FCS:10460 30.06.2026 | 31.03.2026 | 30.06.2025] 30.06.2026 | 31.03.2026 |
[Showing first 8,000 characters — download PDF for full document]